Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Chart shows maintaining this 41 level and going higher is key. If $ADAC keeps its footing here a new support level is established: https://www.barchart.com/stocks/quotes/ADAC/technical-chart?plot=CANDLE&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=HLMA(10,8);RSI(14,100)&sym=ADAC&grid=1&height=500&studyheight=100
Nice synopsis: "About Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF)
Lexington Biosciences is a medical device company developing the HeartSentry, a new non-invasive diagnostic device to measure and monitor cardiovascular health by assessing the function of a person’s vascular endothelium - the vital innermost lining of a person’s cardiovascular system. Currently, the standard of care is measurement using expensive external ultrasound by a highly trained technician. The HeartSentry core technology was developed at the University of California Berkeley over a fifteen-year R&D period involving many research studies and product iterations resulting in a portfolio of multiple pending and issued patents licensed to the company. Our aim is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person’s cardiovascular health. Lexington is engaged with the US FDA and other regulatory agencies on the required product approvals for the HeartSentry. For more information about the company please visit: https://lexingtonbiosciences.com/."
When we break past 5 watch this rocket to the moon $ADAC
Nice close for ADAC, up 12% green
When $LXGTF PR's that the clinical tests with human subjects are officially commenced, BANG, we should see this mooning.
Can't happen soon enough as far as I'm concerned.
Its a race indeed. Have you heard any mention of a buyout? Would be awesome!
Its a race indeed. Have you heard any mention of a buyout? Would be awesome!
$2000 a minute! Cryptocurrency is this generations gold rush. $ADAC CryX launch means $$$$
Endothelial health is probablly something you never think of and have no idea how to measure, but $LXGTF will fix that and HeartSentry might save you from a heartattack.
HOLY COW! "Coinbase revealed that it recorded turnover of $1 billion last year, which works out at an astonishing $2.74 million a day or $2,000 a minute." Who knew? So much money in crypto, great for $ADAC
Endothelial is now a word I'll never forget. Who knew that something you never heard of could mean the differnece between life and death?
Ha, as if some are tired of waiting, but others just now see the oppoortunity
$ADAC is brilliant to launch an online retail platform with a new crypto and partnering with an online trading platform. There are countless new cryptos out there, but when the dust settles its the utility and spendability of a particular currency that will win the day.
$LXGTF churning along in the low 40's. Support levels wont budge. Too much retail support. Wait till they PR that they have begun clinical testing and we should see this really moon.
Lets go up and test that .49 HOD again.
I believe they will be going live very soon. $ADAC
Chart shows $ADAC has broke past resistance and out of the rangebound blahs. RSI not at all overbought yet. A few more pushes on the ask and we should establish a new support level to push into the 5's. https://www.barchart.com/stocks/quotes/ADAC/technical-chart?plot=CANDLE&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=HLMA(10,8);RSI(14,100)&sym=ADAC&grid=1&height=500&studyheight=100
Barchart opinion back up to a 40% buy. https://www.barchart.com/stocks/quotes/ADAC/opinion
BREAKOUT it is $ADAC up green 12%!
Simply put: $LXGTF HeartSentry can save millions of lives once it comes to market in 2018.
One third of all deaths in the modern world are caused by heart attack or stroke. $LXGTF HeartSentry monitor is a device to predict the disease so prevention can happen that will drastically reduce that number.
50% of all heart attacks currently have ZERO diagnostic warning before the attack itself. $LXGTF HeartSentry will change that. Endothelial monitoring can actually predict cardiovascular disease where common measures like blood pressure and cholesterol test cannot.
HeartSentry monitor measures endothelial function (the lining of the blood veins) to test for oncoming heart attack and stroke in time for prevention to happen.
$LXGTF is just awaiting Independent Review Board approval for their HeartSentry monitor device, then clinical tests, FDA clearance and full commercialization anticipated here in 2018. Then BIG revenues expected.
And we know $LXGTF has the funds to see clinicals through also per the Jan 11 announcement:
Yeah, i would agree with all you say but I would say more strongly that, barring some hugely unforeseen hiccup, HeartSentry will see commercialization this year in 2018. LXGTF has scrupulously stuck to their development timeline thus far. With the IRB happening here in the first quarter, that gives plenty of time for the average time of 6 months for clinical trials for cardiovascular devices in the FDA 410K Fast track to market. This is noninvasive technology and the pretrials showed strong correlation to predicate endothelial measurement devices, so this should be a shoe-in, barring some crazy lightning bolt from the sky type disruptive event.
Back down to green 4.1% Was it a fat finger trade? Or are we witnessing the breakout beginings? $ADAC
$LXGTF starting out at .41 on a smattering of volume. Support is iron at this level so expecting the climb up.
Like the crypto markets, time to see the BOUNCE! $ADAC
BAM! There you go, 9.6% green bounce out the gate for $ADAC!
Great news on Jan 18th. All expect $LXGTF to cruise past the IRB stage:
Good morning $ADAC!
$LXGTF getting ready for the bounce!
Let's see what $ADAC will do today.
Good point, could it be part of why they are "internationally reporting"?
At least the green closing reflects that the Buy vol outweighed the Sell vol today. What I really dont get are the days were we have stronger buys but still end up red. How in the world?!? MM's bunch of bozos.
$LXGTF is a bagain at this level. Really a bargain anywhere up to a dollar until FDA clearance.
The impact that $LXGTF HeartSentry device can have on the current medical scene is really incalcuable. We are not talking here about some improvement in cosmertic surgery, or weight loss, we are talking about taking on and defeating the issue behing one third of all deaths in the modern world.